Literature DB >> 23211876

Prevalence of metabolic syndrome and associated factors in women aged 35 to 65 years who were enrolled in a family health program in Brazil.

Ana Carolina Basso Schmitt1, Maria Regina Alves Cardoso, Heno Lopes, Wendry Maria Paixão Pereira, Elaine Cristina Pereira, Debora Aparecida Paccola de Rezende, Rubia Guibo Guarizi, Mayra Cecilia Dellu, Jéssica de Moura Oliveira, Erika Flauzino, Juan E Blümel, José Mendes Aldrighi.   

Abstract

OBJECTIVE: The aims of this study were to estimate the prevalence of metabolic syndrome among women aged 35 to 65 years and to identify associated factors.
METHODS: This was a cross-sectional study. We randomly selected 581 women (aged 35-65 y) from among those enrolled in a family health program in the city of Pindamonhangaba, Brazil. Metabolic syndrome was identified in accordance with the definition of the National Cholesterol Education Program Adult Treatment Panel III. Health conditions and lifestyle habits were evaluated by a survey, and anthropometric measurements were obtained. The prevalence of metabolic syndrome was estimated, and Poisson regression was used to evaluate the associations between metabolic syndrome `and the factors investigated.
RESULTS: The prevalence of metabolic syndrome was 42.2% (95% CI, 38.1-46.2). The most common metabolic syndrome component was abdominal obesity (60.6%), followed by low levels of high-density lipoprotein cholesterol (51.3%), high levels of triglycerides (41.4%), high blood pressure (31.7%), and diabetes (13.9%). The following factors were associated with metabolic syndrome: the 45- to 54-year age group (prevalence ratio, 1.54; 95% CI, 1.08-2.01), the 55- to 65-year age group (prevalence ratio, 3.51; 95% CI, 1.49-3.10), hyperuricemia (prevalence ratio, 2.95; 95% CI, 1.15-1.86), and sleep apnea risk (prevalence ratio, 2.41; 95% CI, 1.16-1.82). We found an inverse association between metabolic syndrome and having had more than 5 years of schooling (prevalence ratio, 0.65; 95% CI, 0.65-1.04).
CONCLUSIONS: The prevalence of metabolic syndrome is high, and the associated clinical factors are hyperuricemia and risk of sleep apnea.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23211876     DOI: 10.1097/gme.0b013e318272c938

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  4 in total

Review 1.  Obesity in CKD--what should nephrologists know?

Authors:  Peter Stenvinkel; Carmine Zoccali; T Alp Ikizler
Journal:  J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 10.121

2.  Chronic joint pain and handgrip strength correlates with osteoporosis in mid-life women: a Singaporean cohort.

Authors:  S Logan; W P P Thu; W K Lay; L Y Wang; J A Cauley; E L Yong
Journal:  Osteoporos Int       Date:  2017-06-24       Impact factor: 4.507

3.  Metabolic syndrome in premenopausal and postmenopausal women with type 2 diabetes: loss of protective effects of premenopausal status.

Authors:  Manouchehr Nakhjavani; Mehrnaz Imani; Mehrdad Larry; Arash Aghajani-Nargesi; Afsaneh Morteza; Alireza Esteghamati
Journal:  J Diabetes Metab Disord       Date:  2014-11-23

Review 4.  Clinical consequences and economic costs of untreated obstructive sleep apnea syndrome.

Authors:  Melissa Knauert; Sreelatha Naik; M Boyd Gillespie; Meir Kryger
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2015-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.